Clinical Trial Update: Effects of Linagliptin on Left Ventricular Myocardial DYsfunction in Patients With Type 2 DiAbetes Mellitus and Concentric Left Ventricular Geometry [Phase 3]

View source ↗

Summary

Phase 3 trial investigating the effects of linagliptin on left ventricular dysfunction in patients with type 2 diabetes and concentric left ventricular geometry…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Left Ventricular Systolic Dysfunction
• Type 2 Diabetes Mellitus

Drugs mentioned

• Linagliptin (linagliptin)

Snippet

Sponsor: Heart Care Foundation | Conditions: Diabetes Mellitus, Type 2, Left Ventricular Systolic Dysfunction | Phase 3 | Status: COMPLETED